Civic

Join us for two events at the University of Maryland BioPark focused around the health and sciences sector. How do we work together to ensure Baltimore's vibrant health and sciences community continues to grow, innovate and thrive?

Monday, September 28 8am–3pm

Track Day Events

  • Health & Sciences Lunchtime Roundtable

    How do we work together to ensure Baltimore's vibrant health and sciences community continues to grow, innovate and thrive? Participate in an intimate lunch with a curated group of entrepreneurs, investors, policy makers, academics and leaders to discuss plans for the future and steps to get there.

    Monday, September 28, 11:30am–1:00pm
  • Switch Baltimore

    Interested in the trends in health and sciences focused around the Baltimore region? Join us for Switch Baltimore on Monday, Sept 28th as we "switch" up the conversation and focus on the future of Health & Science IT.

    Monday, September 28, 1:00pm–4:00pm

Speakers

  • Dr. Christopher W. Kersey

    Dr. Christopher W. Kersey

    Christopher W. Kersey is a Partner and Managing Member of Camden Partners, where he focuses on private equity investments in the health care and business services industries. Dr. Kersey serves as the Chairman of the Board of Johns Hopkins Medicine International, the development arm of Johns

  • M. Jason Brooke

    M. Jason Brooke

    M. Jason Brooke is the Chief Executive Officer and General Counsel for Vasoptic Medical Inc., an early stage medical device company developing a mobile health solution for early detection of diabetic retinopathy. Mr. Brooke has more than 10 years of experience in design, development, and

  • Rana Quraishi

    Rana Quraishi

    Rana Quraishi has spent much of her career working in life science directed finance, investment and consulting organizations. At the TCG Group, a premiere private equity firm she focused on business development opportunities for its life science companies. Prior to this she was a Principal at

  • Miriam Boer

    Miriam Boer

    Miriam Boer is the founder and CTO of Sonify Biosciences. A biochemist by training, she drives Sonify's pioneering research in developing a device using low intensity ultrasound to treat melanoma and other skin cancers. She has extensive experience starting non-spinout biotech companies and

  • Sebastian Seiguer

    Sebastian Seiguer

    Sebastian Seiguer is the CEO of emocha, a mobile health platform that streamlines the continuum of care. From screening all the way through to medication adherence, emocha smartphone and web applications engage the patient and allow various providers to access critical patient information in a

University of Maryland BioPark
801 West Baltimore Street

Track Supported by

Track Collaborators